Immunoproteasome Inhibitors for the Treatment of Alzheimer's Disease Grant

Immunoproteasome Inhibitors for the Treatment of Alzheimer's Disease .

date/time interval

  • February 1, 2023 - April 30, 2026

awarded by

administered by

sponsor award ID

  • 5R01AG073122-05

contributor